Clinical
The Time Is Now to Promote Aggressive Lipid Management to Prevent Macrovascular Complications in Patients with Type 2 Diabetes
Nicole D. White, PharmD, CDE, Thomas L. Lenz, PharmD, FACLM, Maryann Z. Skrabal, PharmD, CDE, Jessica J. Skradski, PharmD, Louis Lipari, PharmD candidate
Influencing Patient Outcomes Through Enhanced Multidisease-Focused Interventions
Kathryn Fitch, RN, MEd, Thomas Weisman, MD,MBA, Tyler Engel, ASA, MAAA, Adam Turpcu, PhD, Helen Blumen, MD, MBA, Yamina Rajput, MS, Purav Dave, MS, MBA
The Economics of Screening Patients with Diabetes for Diabetic Retinopathy
JoAnne Foody, MD, Robin S. Turpin, PhD, Beni A. Tidwell, BS, Debra Lawrence, PhD, Kathy L. Schulman, MS
The Growing Role of Real-World Evidence in Clinical Decision-Making
John T. Lynch, MPH, Catherine E. Cooke, PharmD, MS (PHSR), BCPS, PAHM, Jonathan Rosen, MD, Sanjay Gandhi, PhD, Michael F. Bullano, PharmD
Appropriate Medication Selection Key to Cost-Effective Therapy, Patient Adherence
Scott R. Anderson, MS IV, Lindsay Sanders, DO, MPH, Loida D. Nguyen, PharmD, BCPS, Quang T. Nguyen, DO, FACE, FTOS
Improving Hypertension Management in the Elderly a Core Clinical Goal
AHDB Stakeholder Perspective
A First Step Toward Improving the Complex Approach to Metastatic Prostate Cancer Management
Improving Medication Use for Chronic Diseases by Reducing Costs, Increasing Patient Adherence
Drew A. Helmer, MD, MS, Nilanjana Dwibedi, BPharm, MBA, PhD, Mazhgan Rowneki, MPH, Chin-Lin Tseng, DrPH, Dennis Fried, PhD, Danielle Rose, PhD, Nisha Jani, MPH, PhD, Usha Sambamoorthi, PhD
Mental Health Conditions Constitute Significant Comorbidity: The Impact on Potentially Avoidable Hospital Admissions